Literature DB >> 14644037

Phenotypes indicating cytolytic properties of Borrelia-specific interferon-gamma secreting cells in chronic Lyme neuroborreliosis.

C Ekerfelt1, S Jarefors, N Tynngård, M Hedlund, B Sander, S Bergström, P Forsberg, J Ernerudh.   

Abstract

The immuno-pathogenetic mechanisms underlying chronic Lyme neuroborreliosis are mainly unknown. Human Borrelia burgdorferi (Bb) infection is associated with Bb-specific secretion of interferon-gamma (IFN-gamma), which may be important for the elimination of Bb, but this may also cause tissue injury. In order to increase the understanding of the pathogenic mechanisms in chronic neuroborreliosis, we investigated which cell types that secrete IFN-gamma. Blood mononuclear cells from 13 patients with neuroborreliosis and/or acrodermatitis chronicum atrophicans were stimulated with Bb antigen and the phenotypes of the induced IFN-gamma-secreting cells were analyzed with three different approaches. Cells expressing CD8 or TCRgammadelta, which both have cytolytic properties, were the main phenotypes of IFN-gamma-secreting cells, indicating that tissue injury in chronic neuroborreliosis may be mediated by cytotoxic cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14644037     DOI: 10.1016/j.jneuroim.2003.08.037

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  9 in total

1.  Reduced number of interleukin-12 secreting cells in patients with Lyme borreliosis previously exposed to Anaplasma phagocytophilum.

Authors:  S Jarefors; M Karlsson; P Forsberg; I Eliasson; J Ernerudh; C Ekerfelt
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

2.  Decreased up-regulation of the interleukin-12Rbeta2-chain and interferon-gamma secretion and increased number of forkhead box P3-expressing cells in patients with a history of chronic Lyme borreliosis compared with asymptomatic Borrelia-exposed individuals.

Authors:  S Jarefors; C K Janefjord; P Forsberg; M C Jenmalm; C Ekerfelt
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

3.  Borrelia burgdorferi infection regulates CD1 expression in human cells and tissues via IL1-β.

Authors:  Konstantin Yakimchuk; Carme Roura-Mir; Kelly G Magalhaes; Annemieke de Jong; Anne G Kasmar; Scott R Granter; Ralph Budd; Allen Steere; Victor Pena-Cruz; Carsten Kirschning; Tan-Yun Cheng; D Branch Moody
Journal:  Eur J Immunol       Date:  2011-01-18       Impact factor: 5.532

4.  Interaction of the Lyme disease spirochete Borrelia burgdorferi with brain parenchyma elicits inflammatory mediators from glial cells as well as glial and neuronal apoptosis.

Authors:  Geeta Ramesh; Juan T Borda; Jason Dufour; Deepak Kaushal; Ramesh Ramamoorthy; Andrew A Lackner; Mario T Philipp
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307

Review 5.  Lyme disease: aetiopathogenesis, factors for disease development and control.

Authors:  I R Kean; K L Irvine
Journal:  Inflammopharmacology       Date:  2012-10-31       Impact factor: 4.473

6.  A possible role for inflammation in mediating apoptosis of oligodendrocytes as induced by the Lyme disease spirochete Borrelia burgdorferi.

Authors:  Geeta Ramesh; Shemi Benge; Bapi Pahar; Mario T Philipp
Journal:  J Neuroinflammation       Date:  2012-04-23       Impact factor: 8.322

7.  Indications of Th1 and Th17 responses in cerebrospinal fluid from patients with Lyme neuroborreliosis: a large retrospective study.

Authors:  Anna J Henningsson; Ivar Tjernberg; Bo-Eric Malmvall; Pia Forsberg; Jan Ernerudh
Journal:  J Neuroinflammation       Date:  2011-04-20       Impact factor: 8.322

Review 8.  Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain.

Authors:  Geeta Ramesh; Andrew G MacLean; Mario T Philipp
Journal:  Mediators Inflamm       Date:  2013-08-12       Impact factor: 4.711

9.  Possible role of glial cells in the onset and progression of Lyme neuroborreliosis.

Authors:  Geeta Ramesh; Juan T Borda; Amy Gill; Erin P Ribka; Lisa A Morici; Peter Mottram; Dale S Martin; Mary B Jacobs; Peter J Didier; Mario T Philipp
Journal:  J Neuroinflammation       Date:  2009-08-25       Impact factor: 9.587

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.